NCT02205398 2019-01-22Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab TherapyNovartisPhase 1 Terminated13 enrolled